Skip to main content Back to Top
Advertisement

10/9/2019

Midodrine Tablets

Products Affected - Description

    • Midodrine tablets oral tablet, Amneal, 2.5 mg, 100 count, NDC 00115-4211-01 - discontinued
    • Midodrine tablets oral tablet, Sandoz, 10 mg, 100 count, NDC 00185-0149-01 - discontinued
    • Midodrine tablets oral tablet, Sandoz, 2.5 mg, 100 count, NDC 00185-0040-01 - discontinued
    • Midodrine tablets oral tablet, Sandoz, 5 mg, 100 count, NDC 00185-0043-01 - discontinued
    • Midodrine tablets oral tablet, Sandoz, 5 mg, 500 count, NDC 00185-0043-05 - discontinued

Reason for the Shortage

    • Apotex has midodrine tablets available.
    • Impax discontinued midodrine tablets in July 2018.
    • Mylan has midodrine 5 mg tablets available.
    • Sandoz discontinued midodrine tablets in mid-2018.
    • Upsher-Smith has midodrine tablets available.

Available Products

    • Midodrine tablets oral tablet, Apotex, 10 mg, 100 count, NDC 60505-1325-01
    • Midodrine tablets oral tablet, Apotex, 2.5 mg, 100 count, NDC 60505-1320-01
    • Midodrine tablets oral tablet, Apotex, 5 mg, 100 count, NDC 60505-1321-01
    • Midodrine tablets oral tablet, Mylan, 5 mg, 100 count, NDC 51079-0453-20
    • Midodrine tablets oral tablet, Upsher-Smith, 10 mg, 100 count, NDC 00245-0213-11
    • Midodrine tablets oral tablet, Upsher-Smith, 2.5 mg, 100 count, NDC 00245-0211-11
    • Midodrine tablets oral tablet, Upsher-Smith, 5 mg, 100 count, NDC 00245-0212-11

Updated

Updated October 9, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. Created June 13, 2018 by Anthony Trovato, PharmD, BCPS. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.